Lamellolamellar sclerokeratoplasty. Where do we stand today?

被引:9
|
作者
Panda, A [1 ]
机构
[1] AIIAMS, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi, India
关键词
sclerokeratoplasty; Dessmarre's corneal dissector; King's clamp; glycerin-preserved; Mooren's ulcer; squamous cell carcinoma;
D O I
10.1038/eye.1999.55
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose To determine the efficacy of lamellar sclerokeratoplasty for patients with extensive cornea/corneoscleral lesions. Methods One hundred and sixty-six eyes with extensive corneal/corneoscleral lesions of different aetiology who were poor candidates for conventional lamellar keratoplasty/penetrating keratoplasty were selected for lamellar sclerokeratoplasty. Results Corneal clarity of 3+ or more was achieved in 62 eyes by a single procedure. In the remaining 104 eyes graft clarity was < 2+ due to post-surgical complications (n = 56) or remaining recipient deep opacity (n = 48). Conclusions Astigmatism, the bugbear of final visual achievement despite a clear graft, was not a frequent problem following lamellar sclerokeratoplasty. Similarly, a gain in visual acuity to 6/18 or more in 30% of eyes, cosmetic improvement in the majority of cases and prevention of recurrence of the original disease process in susceptible cases all point towards the safety and effectiveness of the procedure. Thus, lamellar sclerokeratoplasty should be considered as a management option for patients with extensive corneal/corneoscleral lesions.
引用
收藏
页码:221 / 225
页数:5
相关论文
共 50 条
  • [41] Estrogens in vascular biology and disease:: where do we stand today?
    Arnal, Jean-Francois
    Scarabin, Pierre-Yves
    Tremollieres, Florence
    Laurell, Henrik
    Gourdy, Pierre
    CURRENT OPINION IN LIPIDOLOGY, 2007, 18 (05) : 554 - 560
  • [42] Early diagnosis of systemic sclerosis, where do we stand today?
    Lepri, Gemma
    Bellando Randone, Silvia
    Matucci Cerinic, Marco
    Guiducci, Serena
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2022, 18 (01) : 1 - 3
  • [43] AFFIRMATIVE ACTION IN PUBLIC SECOR - WHERE DO WE STAND TODAY
    DANIELSO.WF
    PUBLIC ADMINISTRATION REVIEW, 1974, 34 (03) : 241 - 242
  • [44] Split livers and living donors -: where do we stand today?
    Hertl, M
    Malagó, M
    Testa, G
    Broelsch, CE
    HEPATOLOGY 2000: SYMPOSIUM IN HONOR OF GUSTAV PAUMGARTNER, 2001, 117 : 293 - 302
  • [45] Carotid endarterectomy versus stenting: Where do we stand today?
    Boztosun, Bilal
    Can, Mehmet Mustafa
    Kocabay, Gonenc
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2012, 40 (07): : 642 - 649
  • [46] The mold conundrum in chronic rhinosinusitis: Where do we stand today?
    Fenna A. Ebbens
    Wytske J. Fokkens
    Current Allergy and Asthma Reports, 2008, 8
  • [47] Ocular nonsteroidal inflammatory drugs: where do we stand today?
    Kandarakis, S. A.
    Petrou, P.
    Papakonstantinou, E.
    Spiropoulos, D.
    Rapanou, A.
    Georgalas, I.
    CUTANEOUS AND OCULAR TOXICOLOGY, 2020, 39 (03) : 200 - 212
  • [48] Pediatric Dental Sedation Research: Where Do We Stand Today?
    Mittal, N.
    Goyal, A.
    Jain, K.
    Gauba, K.
    JOURNAL OF CLINICAL PEDIATRIC DENTISTRY, 2015, 39 (03) : 284 - 291
  • [49] Laparoscopy for Liver Hydatid Disease: Where Do We Stand Today?
    Sharma, Deborshi
    Babu, Raghavendra
    Borgharia, Saurabh
    Baruah, Dhiraj
    Thomas, Shaji
    Kumar, Ajay
    SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES, 2009, 19 (06): : 419 - 423
  • [50] Intrahepatic Cholangiocarcinoma - Where Do We Stand Today? Literature Review
    Savin, Catalin
    Tarca, Luiza
    Eftimie, Mihai
    Balescu, Irina
    Petrea, Sorin
    Diaconu, Camelia
    Gaspar, Bogdan
    Pop, Lucian
    Varlas, Valentin
    Hasegan, Adrian
    Martac, Cristina
    Bolca, Ciprian
    Stroescu, Cezar
    Stoian, Marilena
    Gorecki, Gabriel Petre
    Bacalbasa, Nicolae
    CHIRURGIA, 2023, 118 (06) : 553 - 567